Dublin, Jan. 08, 2024 (GLOBE NEWSWIRE) — The “microRNA (miRNA) – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.
Global microRNA (miRNA) Market to Reach $840.8 Million by 2030
The global market for microRNA (miRNA) estimated at US$282.6 Million in the year 2022, is projected to reach a revised size of US$840.8 Million by 2030, growing at a CAGR of 14.6% over the analysis period 2022-2030.
The report delves into the global landscape of microRNA (miRNA) in 2022, offering insights into the market’s competitive dynamics. It assesses the Global Key Competitors’ Percentage Market Share for the year 2022, categorizing their Competitive Market Presence as strong, active, niche, or trivial.
Products, one of the segments analyzed in the report, is projected to record 12.9% CAGR and reach US$419.6 Million by the end of the analysis period. Growth in the Services segment is estimated at 16.5% CAGR for the next 8-year period.
The report begins with an introduction to miRNA, setting the stage for a comprehensive understanding of this field. It then discusses the impact of the COVID-19 pandemic on the mRNA market, providing context for the subsequent analysis. Global market prospects and outlook for miRNA are presented, indicating that the miRNA market is poised for rapid growth. Within this market, the Disease Diagnostics segment leads the way, with miRNAs expected to play a crucial role in disease diagnosis and treatment.
The instruments category is explored, highlighting the dominance of Polymerase Chain Reaction (PCR) technologies. Academic and government research institutes are identified as the major stakeholders in the miRNA market.
Competition in the miRNA market is underlined, with a growing emphasis on research and development activities by key players as a driving force behind market growth. This report provides a comprehensive overview of the miRNA market, its competitive landscape, and its potential for significant expansion in the near future.
The U.S. Market is Estimated at $120.5 Million, While China is Forecast to Grow at 18.6% CAGR
Geographically, North America stands out as the dominant player, while the Asia-Pacific region is expected to witness steady growth in the miRNA market.
The microRNA (miRNA) market in the U.S. is estimated at US$120.5 Million in the year 2022. China, the world’s second largest economy, is forecast to reach a projected market size of US$99.9 Million by the year 2030 trailing a CAGR of 18.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.8% and 13.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 13.2% CAGR.
What`s New?
- Special discussions on the global economic climate and market sentiment
- Coverage on global competitiveness and key competitor percentage market shares
- Market presence analysis across multiple geographies – Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and trademarked research platform
- Complimentary updates for one year
- Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 379 |
| Forecast Period | 2022 – 2030 |
| Estimated Market Value (USD) in 2022 | $282.6 Million |
| Forecasted Market Value (USD) by 2030 | $840.8 Million |
| Compound Annual Growth Rate | 14.6% |
| Regions Covered | Global |
MARKET TRENDS & DRIVERS
- Increasing Incidence of Infectious Diseases and Chronic Conditions to Help miRNA Market Gallop Ahead
- Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
- Increasing Application in Cancer Diagnostics as Biomarkers to Drive Market Growth
- Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
- Breakdown of Total Number of Cancer Cases by Region: 2020
- Breakdown of Total Number of Cancer Cases by Type: 2020
- The Future of miRNA-based Cancer Biomarkers
- Consistent Increase in Risks and Threats from Infections Drive Healthy Market Growth
- Global Number of Deaths Caused Due to Communicable Diseases (In 000s)
- Infection Rates of Viruses ((per infected person)) Involved in Outbreaks Worldwide: 2020
- Infectious Diseases Related Mortality High Among Children below 5 Years: Breakdown of Leading Causes of Death in Children below 5 Years (in %)
- MicroRNA Biomarkers Hold Promise for Diagnosis of Infectious Diseases
- Focus on Development of miRNA-based Therapeutics Bodes Well for Market Growth
- Increasing Investments in miRNA to Bolster Market Growth
- Diagnostics and Therapeutics Investments
- Standard Methods Utilized to measure miRNA Biomarkers
- Advancements in Detection Methodologies Focus on Enhancing Sensitivity and Selectivity of miRNA Detection
- Increasing Demand for Liquid Biopsies to Drive the MicroRNA Market
- miRNA by Type of Gastrointestinal Cancers
- Circulating miRNAs as Cancer Detectors
- Aging Demographics Add to the Global Burden of Chronic Diseases, Presenting Opportunities for the Market
- Expanding Elderly Population Worldwide: Breakdown of Number of People Aged 65+ Years in Million by Geographic Region for the Years 2019 and 2030
- Growing Global Healthcare Spending and Supportive Government Initiatives Boost Market Prospects
- World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
- Per Capita Healthcare Expenditure (in $) by Select Countries for 2018
- miRNA and Next Generation Sequencing
- Market Restraints
- An Insight Into Mirna Applications
- Cancer
- Role Of Mirna In Cancer Cell
- Dna Repair And Cancer
- Heart Disease
- Mirna-712
- Human Homolog – Microrna-205
- Kidney Disease
- Nervous System
- Stroke
- Alcoholism
- Obesity
- Hemostasis
FOCUS ON SELECT PLAYERS(Total 64 Featured)
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Abcam PLC
- BioVendor – Laboratorni medicina a.s
- GeneCopoeia, Inc.
- AKESOgen, Inc.
- Entos Pharmaceuticals
- Genomnia
- Guangzhou Ruibo Biotechnology Co., Ltd.
- 20Med Therapeutics
- AceRNA Technologies Co., Ltd.
- AptamiR Therapeutics
- Causeway Therapeutics
- Cardior Pharmaceuticals
- Craif
For more information about this report visit https://www.researchandmarkets.com/r/4tzda0
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
